Alivion

📍 Zürich, Switzerland🗓 Founded 2020👥 14 employees💰 Last funded Oct 2024
At Alivion, we believe that precise determination of substances and biomarkers can significantly enhance our lives. The desire for a long and healthy life grows with increasing life expectancy. Measuring biomarkers in our breath allows for a healthy lifestyle and provides crucial dietary information, especially for those dealing with weight issues. Improving personal lifestyle choices can prevent cardiovascular diseases and diabetes, paving the way for a long and healthy life. How Does Alivion Work? The portable Alivion SmartSelect™ offers near real-time, laboratory-level analysis of substances anytime, anywhere. Our technology, built on over 15 years of research at ETH Zurich, uses headspace gas chromatography to identify substances in body’s breath and liquids. Alivion’s groundbreaking innovation has earned several internationala wards.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2020
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Spain
1
Frequently asked questions
Who invested in Alivion?
Alivion has 1 investors on record on gritt.io, 1 mid-stage.
When did Alivion last raise funding?
The most recent investment in Alivion recorded on gritt.io was in October 2024.
When was Alivion founded?
Alivion was founded in 2020.
What industry is Alivion in?
Alivion operates in Wellness and Fitness Services. Find similar Wellness and Fitness Services investors on gritt.io.
Where is Alivion based?
Alivion is headquartered in Zürich, Switzerland.